Burkholderia cepacia - Revision history

Elcatracho: /* Background */

2021-03-24T18:50:15Z

Background

← Older revision		Revision as of 18:50, 24 March 2021
Line 1:		Line 1:
	==Background==		==Background==
	*~~Infection~~ occurs in patients who are immune suppressed or those with chronic lung disease (e.g. [[cystic fibrosis]])		*[[Gram-negative]] bacteria causing infection that occurs in patients who are immune suppressed or those with chronic lung disease (e.g. [[cystic fibrosis]])
	*Often resistant to multiple antibiotics		*Often resistant to multiple antibiotics

Elcatracho: /* Background */

2021-03-24T18:48:47Z

Background

← Older revision		Revision as of 18:48, 24 March 2021
Line 1:		Line 1:
	==Background==		==Background==
	*Infection occurs in patients who are immune suppressed or those with chronic lung disease (e.g. cystic fibrosis)		*Infection occurs in patients who are immune suppressed or those with chronic lung disease (e.g. [[cystic fibrosis]])
	*Often resistant to multiple antibiotics		*Often resistant to multiple antibiotics

Mholtz: Text replacement - "* " to "*"

2017-07-24T01:12:56Z

Text replacement - "* " to "*"

← Older revision		Revision as of 01:12, 24 July 2017
Line 1:		Line 1:
	==Background==		==Background==
	* Infection occurs in patients who are immune suppressed or those with chronic lung disease (e.g. cystic fibrosis)		*Infection occurs in patients who are immune suppressed or those with chronic lung disease (e.g. cystic fibrosis)
	* Often resistant to multiple antibiotics		*Often resistant to multiple antibiotics

	==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==		==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==

Rossdonaldson1: /* Background */

2017-04-19T22:10:29Z

Background

← Older revision		Revision as of 22:10, 19 April 2017
Line 1:		Line 1:
	==Background==		==Background==
	* Infection occurs in patients who are immune suppressed or those with chronic lung disease (eg) ~~Cystic Fibrosis~~		* Infection occurs in patients who are immune suppressed or those with chronic lung disease (e.g. cystic fibrosis)
	* Often resistant to multiple antibiotics		* Often resistant to multiple antibiotics

TJYE: /* Background */

2017-04-09T20:12:07Z

Background

← Older revision		Revision as of 20:12, 9 April 2017
Line 1:		Line 1:
	==Background==		==Background==
			* Infection occurs in patients who are immune suppressed or those with chronic lung disease (eg) Cystic Fibrosis
			* Often resistant to multiple antibiotics

	==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==		==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==

Rossdonaldson1: Created page with "==Background== ==Antibiotic SensitivitiesSanford Guide to Antimicrobial Therapy 2014== {| class="wikitable" | align="center" style="background:#f0f0f0;"|'''Cat..."

2014-06-24T02:17:48Z

Created page with "==Background== ==Antibiotic Sensitivities<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>== {| class="wikitable" | align="center" style="background:#f0f0f0;"|'''Cat..."

New page

==Background==

==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==
{| class="wikitable"
| align="center" style="background:#f0f0f0;"|'''Category'''
| align="center" style="background:#f0f0f0;"|'''Antibiotic'''
| align="center" style="background:#f0f0f0;"|'''Sensitivity'''
|-
| [[Penicillins]]||[[Penicillin G]]||R
|-
| ||[[Penicillin V]]||R
|-
| Anti-Staphylocccal [[Penicillins]]||[[Methicillin]]||R
|-
| ||[[Nafcillin]]/[[Oxacillin]]||R
|-
| ||[[Cloxacillin]]/[[Diclox.]]||R
|-
| Amino-[[Penicillins]]||[[AMP]]/[[Amox]]||R
|-
| ||[[Amox-Clav]]||R
|-
| ||[[AMP-Sulb]]||R
|-
| Anti-Pseudomonal [[Penicillins]]||[[Ticarcillin]]||R
|-
| ||[[Ticar-Clav]]||X1
|-
| ||[[Pip-Tazo]]||X1
|-
| ||[[Piperacillin]]||X1
|-
| [[Carbapenems]]||[[Doripenem]]||I
|-
| ||[[Ertapenem]]||R
|-
| ||[[Imipenem]]||R
|-
| ||[[Meropenem]]||'''S'''
|-
| ||[[Aztreonam]]||R
|-
| [[Fluroquinolones]]||[[Ciprofloxacin]]||R
|-
| ||[[Ofloxacin]]||R
|-
| ||[[Pefloxacin]]||X1
|-
| ||[[Levofloxacin]]||X1
|-
| ||[[Moxifloxacin]]||R
|-
| ||[[Gemifloxacin]]||X1
|-
| ||[[Gatifloxacin]]||R
|-
| 1st G [[Cephalo]]||[[Cefazolin]]||R
|-
| 2nd G. [[Cephalo]]||[[Cefotetan]]||R
|-
| ||[[Cefoxitin]]||R
|-
| ||[[Cefuroxime]]||R
|-
| 3rd/4th G. [[Cephalo]]||[[Cefotaxime]]||I
|-
| ||[[Cefizoxime]]||I
|-
| ||[[CefTRIAXone]]||I
|-
| ||[[Ceftaroline]]||R
|-
| ||[[CefTAZidime]]||'''S'''
|-
| ||[[Cefepime]]||I
|-
| Oral 1st G. [[Cephalo]]||[[Cefadroxil]]||R
|-
| ||[[Cephalexin]]||R
|-
| Oral 2nd G. [[Cephalo]]||[[Cefaclor]]/[[Loracarbef]]||R
|-
| ||[[Cefproxil]]||R
|-
| ||[[Cefuroxime axetil]]||R
|-
| Oral 3rd G. [[Cephalo]]||[[Cefixime]]||R
|-
| ||[[Ceftibuten]]||'''S'''
|-
| ||[[Cefpodox]]/[[Cefdinir]]/[[Cefditoren]]||X1
|-
| [[Aminoglycosides]]||[[Gentamicin]]||R
|-
| ||[[Tobramycin]]||R
|-
| ||[[Amikacin]]||R
|-
| ||[[Chloramphenicol]]||'''S'''
|-
| ||[[Clindamycin]]||R
|-
| [[Macrolides]]||[[Erythromycin]]||R
|-
| ||[[Azithromycin]]||R
|-
| ||[[Clarithromycin]]||R
|-
| Ketolide||[[Telithromycin]]||R
|-
| Tetracyclines||[[Doxycycline]]||R
|-
| ||[[Minocycline]]||I
|-
| Glycylcycline||[[Tigecycline]]||I
|-
| ||[[Daptomycin]]||R
|-
| Glyco/Lipoclycopeptides||[[Vancomycin]]||R
|-
| ||[[Teicoplanin]]||R
|-
| ||[[Telavancin]]||R
|-
| ||[[Fusidic Acid]]||R
|-
| ||[[Trimethoprim]]||'''S'''
|-
| ||[[TMP-SMX]]||'''S'''
|-
| Urinary Agents||[[Nitrofurantoin]]||R
|-
| ||[[Fosfomycin]]||X1
|-
| Other||[[Rifampin]]||R
|-
| ||[[Metronidazole]]||R
|-
| ||[[Quinupristin dalfoppristin]]||X1
|-
| ||[[Linezolid]]||R
|-
| ||[[Colistimethate]]||R
|}

===Key===
{{Template:Antibacterial Spectra Key}}

==Table Overview==
{{Clinically Relevant Bacteria}}

==See Also==
*[[Microbiology (Main)]]

==References==
<references/>

[[Category:ID]]